Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Use of Benzodiazepines in Anxiety Disorders

Wood, Alastair J.J., Shader, Richard I., Greenblatt, David J. · 1993 · New England Journal of Medicine

Abstract

Beginning with chlordiazepoxide in 1960, benzodiazepines have been used extensively for the treatment of anxiety and related disorders. Eight benzodiazepine derivatives have been approved by the Food and Drug Administration for this purpose (Table 1). Another benzodiazepine, clonazepam, is also prescribed for this purpose but is labeled as an anticonvulsant.The clinical, pharmacokinetic, and neurochemical properties of the benzodiazepine derivatives have been the focus of many articles in the scientific literature16. Much is known about their molecular mechanisms of action, properties of distribution and elimination, clinical activity, and side effects. Like many other classes of drugs that are . . .

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199305133281907

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 95 references

Research works printed but not linked: 18

  1. Garattini S, Mussini E, Randall LO, eds. The benzodiazepines. New York: Raven Press, 1973.
  2. Usdin E, Skolnick P, Tallman JF, Greenblatt D, Paul SM, eds. Pharmacology of benzodiazepines. London: MacMillan Press, 1982.
  3. Pollack MH, 1990, J Clin Psychiatry, 51, 12
  4. Woods JH, 1992, Pharmacol Rev, 44, 151
  5. Greenblatt DJ, Shader RI. Pharmacokinetics of antianxiety agents. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1377-86.
  6. Greenblatt DJ, Shader RI. Pharmacotherapy of anxiety with benzodiazepines and β-adrenergic blockers. In: Lipton MA, DiMascio A, Killam KF, eds. Psychopharmacology: a generation of progress. New York: Raven Press, 1978:1381-90.
  7. Munjack DJ, 1989, J Clin Psychopharmacol, 9, 22
  8. Schweizer E, 1988, Psychopharmacol Bull, 24, 224
  9. Charney DS, 1989, J Clin Psychiatry, 50, 418
  10. Tesar GE, 1991, J Clin Psychiatry, 52, 69
  11. Haefely WE. The GABAA-benzodiazepine receptor: biology and pharmacology. In: Burrows GD, Roth M, Noyes R, eds. Handbook of anxiety. Vol. 3. The neurobiology of anxiety. Amsterdam: Elsevier, 1990:165-88.
  12. Miller LG, 1987, J Pharmacol Exp Ther, 240, 516
  13. Hindmarch I, 1991, Alcohol Alcohol, 26, 71
  14. Miller LG, 1988, J Pharmacol Exp Ther, 246, 170
  15. Dietch JT, 1988, J Clin Psychiatry, 49, 184
  16. Woods JH, 1987, Pharmacol Rev, 39, 251
  17. Noyes R, 1988, J Clin Psychiatry, 49, 382
  18. Lader M, 1983, J Clin Psychiatry, 44, 121

Cited by

See all 345

Metadata

Authors
Wood, A. J. J., Shader, R. I., & Greenblatt, D. J.
Affiliations
Tufts University (US)
Venue
New England Journal of Medicine
Published
1993-05-13
Volume
328
Issue
19
Pages
1398-1405
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2324278286
Cited by
341
References
95
Citations by year
2026: 7 · 2025: 6 · 2024: 4 · 2023: 10 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 10 · 2012: 15
FWCI
6.73
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (MH 34223)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
benzodiazepines, anxiety disorders, chlordiazepoxide, clonazepam, benzodiazepine derivatives, pharmacokinetics, mechanism of action, adverse effects
MeSH terms
Anxiety Disorders, Benzodiazepines, Drug Tolerance, Humans, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of Benzodiazepines in Anxiety Disorders. https://app.cochat.ai/papers/10.1056/nejm199305133281907
The paper
Wood, A. J. J., Shader, R. I., & Greenblatt, D. J. (1993). Use of Benzodiazepines in Anxiety Disorders. New England Journal of Medicine. https://doi.org/10.1056/nejm199305133281907

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.